Small opportunities are turning into big business for Joe Krivulka and Reliant Pharmaceuticals LLC,
the company he co-founded just two years ago. Mr. Krivulka is seizing the opportunity to breathe new life into products being cast off by the pharmaceutical giants.
“Big pharma has products that are doing $100 million to $200 million in sales, but are under-loved,” Mr. Krivulka says. “Big pharmaceutical companies just don’t have the time to do line extensions or create additional value for some of the products in their portfolios. They’re focusing, and rightfully so, on bigger products that will add shareholder value.”
Reliant Pharmaceuticals, one of the fastest-growing pharmaceutical companies in the U.S., acquires, develops, and markets products with the potential to significantly improve the treatment and management of diseases affecting…
Growth Through Acquisition
Building a Company